Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: Impact on the outcome.
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To evaluate whether appropriate early empirical glycopeptide therapy improves outcomes of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia. METHODS: We retrospectively collected the data for all adult patients with confirmed MRSA bacteraemia diagnosed and treated at National Taiwan University Hospital during the period 1 April 1997-31 March 2001, and followed their survival up to three years. The main outcome measures were MRSA-related death and all-cause mortality. RESULTS: There were 77 MRSA-related deaths among 162 patients. There was no statistically significant difference in MRSA-related deaths between patients receiving glycopeptides before or within 48 h after blood culture (n = 43) (55%, 18/33, non-septic shock group; 90%, 9/10, septic shock group) or those whose glycopeptide therapy was begun more than 48 h after blood culture (n = 119) (37%, 40/107, non-septic shock group; 83%, 10/12, septic shock group) (P = 0.11 and 1.00, respectively). The outcome measure of all-cause mortality from 30 days to 3 years yields similar results. Multivariate logistic regression analysis and Cox analysis showed that the length of delay (daily increment) between blood culture sampling and start of glycopeptide therapy did not have a statistically significant impact on MRSA-related death or all-cause 30-day mortality after adjusting for the effect of other variables [adjusted odds ratio 0.99, 95% confidence interval (95% CI) 0.88-1.12; adjusted hazard ratio 0.87, 95% CI 0.74-1.02, respectively). CONCLUSIONS: The hypothesis that earlier empirical use of glycopeptide therapy reduces mortality in patients with hospital-acquired MRSA bacteraemia was not supported.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with documented MRSA infections, delays of > 24–48 h until antibiotic administration are associated with increased mortality in some studies [143–147], but not in others [148–154].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [148]
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Gram-Negative Bacteremia: I. Etiology and Ecology
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240029006 · Cited by 1,362
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Methicillin-Resistant Staphylococcus aureus
Brumfitt, W., & Hamilton-Miller, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201806 · Cited by 934
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836
(1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90104-3 · Cited by 709
Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Blot, S. I., Vandewoude, K. H., Hoste, E. A., & Colardyn, F. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2229 · Cited by 463
Huletsky, A., Giroux, R., Rossbach, V., Gagnon, M., Vaillancourt, M., Bernier, M., Gagnon, F., Truchon, K., Bastien, M., Picard, F. J., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1875-1884.2004 · Cited by 408
Gonzalez, C., Rubio, M., Romero-Vivas, J., Gonzalez, M., & Picazo, J. J. (1999) · Clinical Infectious Diseases · doi:10.1086/313440 · Cited by 407
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O’Hara, C. M., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.1020-1027.1998 · Cited by 376
Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O’Hara, C. M., McAllister, S. K., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.2167-2167.1998 · Cited by 362
Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus
Romero-Vivas, J., Rubio, M., Fernandez, C., & Picazo, J. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1417 · Cited by 318
Harbarth, S., Rutschmann, O., Sudre, P., & Pittet, D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.2.182 · Cited by 267
Penetration of vancomycin into human lung tissue
Cruciani, M., Gatti, G., Lazzarini, L., Furlan, G., Broccali, G., Malena, M., Franchini, C., & Concia, E. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.5.865 · Cited by 264
Coello, R., Glynn, J. R., Gaspar, C., Picazo, J. J., & Fereres, J. (1997) · Journal of Hospital Infection · doi:10.1016/s0195-6701(97)90071-2 · Cited by 200
Meticillin-resistant Staphylococcus aureus
Boyce, J. M., Cookson, B., Christiansen, K., Hori, S., Vuopio-Varkila, J., Kocagöz, S., Öztop, A. Y., Vandenbroucke-Grauls, C. M., Harbarth, S., & Pittet, D. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70243-7 · Cited by 187
Long-term Survival Following Bacteremia or Fungemia
Leibovici, L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530100047033 · Cited by 166
Roghmann, M.-C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.1001 · Cited by 130
Pittet, D. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.11.1177 · Cited by 115
Vardakas, K. Z., Samonis, G., Chrysanthopoulou, S. A., Bliziotis, I. A., & Falagas, M. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70164-x · Cited by 104
Kim, S.-H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh366 · Cited by 80
Lodise, T. P., McKinnon, P. S., & Rybak, M. J. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502269 · Cited by 77
Necessity of a loading dose when using vancomycin in critically ill patients
Wang, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.2.246 · Cited by 71
Self-citationHsueh, P., Teng, L., Chen, W.-H., Pan, H.-J., Chen, M., Chang, S., Luh, K., & Lin, F. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1361-1364.2004 · Cited by 66
Self-citationControlling methicillin resistant Staphylococcus aureus
Duckworth, G. (2003) · BMJ · doi:10.1136/bmj.327.7425.1177 · Cited by 62
Ml, C., Sc, C., Hj, P., Hsueh, P., Ls, Y., Sw, H., & Kt, L. (1999) · PubMed · Cited by 37
Self-citationCordova, S., Heath, C. H., McGechie, D. B., Keil, A. D., Beers, M., & Riley, T. V. (2003) · Journal of Hospital Infection · doi:10.1016/j.jhin.2003.10.009 · Cited by 29
Long-term survival following bacteremia or fungemia
Leibovici, L. (1995) · JAMA · doi:10.1001/jama.274.10.807 · Cited by 29
Treatment of staphylococcal infection
Amyes, S. G. B. (2005) · BMJ · doi:10.1136/bmj.330.7498.976 · Cited by 11
Fang, C., Chang, S., Chen, Y., Hsieh, S., & Hsieh, W. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00384-3 · Cited by 8
Self-citationChang, S., Fang, C., Hsueh, P., Luh, K., & Hsieh, W. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00147-3 · Cited by 6
Self-citationNecessity of a loading dose when using vancomycin in critical-ill patients
SOTO, J., Sacristán, J. A., & Alsar, M. J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.6.875 · Cited by 6
Research works printed but not linked: 2
- NINSS report on surgical site infection and hospital-acquired bacteremia. Commun Dis Rep CDR Wkly2000; 10: 213–6.
- Hsieh GY, Chen PC, Wang JD. Verification and correction of error for death registration data of the Department of Health R.O.C. between 1980 and 1997. Taiwan J Public Health2002; 21: 329–38.
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., & Leibovici, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00627-10 · Cited by 724
Paul, M., Kariv, G., Goldberg, E., Raskin, M., Shaked, H., Hazzan, R., Samra, Z., Paghis, D., Bishara, J., & Leibovici, L. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq373 · Cited by 224
Metadata
- Authors
- Fang, C.-T., Shau, W.-Y., Hsueh, P.-R., Chen, Y.-C., Wang, J.-T., Hung, C.-C., Huang, L. Y. L., & Chang, S.-C.
- Affiliations
- National Taiwan University Hospital (TW)
- National Taiwan University (TW)
- Corresponding author
- Fang, Chi-Tai
- ORCID
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-27
- Volume
- 57
- Issue
- 3
- Pages
- 511-519
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2112490859
- Cited by
- 53
- References
- 43
- Citations by year
- 2025: 4 · 2023: 1 · 2022: 1 · 2021: 3 · 2019: 1 · 2018: 2 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 10 · 2012: 2
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Taiwan University Hospital
- National Taiwan University
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- methicillin-resistant Staphylococcus aureus, MRSA bacteremia, septic shock, all-cause mortality, blood culture, nosocomial infections
- MeSH terms
- Adolescent, Adult, Anti-Bacterial Agents, Drug Administration Schedule, Humans, Retrospective Studies, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Methicillin Resistance, Bacteremia, Teicoplanin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.